Tesla should be riding high right now, the electric car maker just unveiled the autonomous car that it has been promising for years, reinvented the bus and pledged to bring humanoid robots to market for the low, low price of $30,000. It isn’t, however, and has instead seen its share price plummet and the enormous…Read…
Host Rev. Paul Brandeis Raushenbush explores the urgent message of the Freedom To Read Day of Community Action with three leaders in the fight against book bans: Dartmouth Librarian Qiana Johnson, Union of Black Episcopalians President Rev. Kim Coleman, and Rabba Rori Picker Neiss of the Jewish Council for Public Affairs…
As a grandmother who has always prided herself on family values and tradition, Marta has found herself at odds with the bold choices her grandson has made. Vibrant blue hair, piercings, and even tattoos have left her feeling disconnected from the boy she once knew. In an attempt to “fix” things…
In a world where stress has become an usual thing, the pursuit of happiness is something everyone strives for a way to find peace, balance, and fulfilment in their lives. It shouldn’t take more work to obtain because it is an essential part of human life…
Albania, which sits across the Adriatic Sea from Italy, was until the early 1990s one of the most isolated communist regimes in the world. But a new migrant camp in the country, under Italian jurisdiction, represents the first time a European Union country has located the processing of asylum claims offshore…
Wednesday 16 October, 2024 London, 16/10/2024 – In light of growing evidence of India’s transnational repression and violence against Sikh activists, we urge the British government and the international community to recognise India as a rogue state and impose sanctions against officials responsible for these actions…
The event is being held to honor those who work tirelessly over the year to help clean up the field of mental health. The awards will be presented during a banquet and live musical performance held at the historic Fort Harrison in Clearwater…
The European Medicines Agency (EMA) has upheld an earlier recommendation to deny marketing authorization for Masitinib AB Science (masitinib), an oral treatment for amyotrophic lateral sclerosis (ALS). In a meeting on October 17, the EMA’s Committee for Medicinal Products for Human Use (CHMP) reaffirmed its concerns about the reliability of the data supporting the drug…